We’re incredibly excited to share that the final 12-month results from our first-in-human trial of SakuraBead are in. The results exceeded our expectations – not just in terms of the data, but also with the impact it had on patients.

Patients with knee osteoarthritis saw their pain drop from ~70/100 pre-treatment to ~10/100 at 12 months. But beyond the numbers, the real story is the meaningful difference it made in the day to day lives of those treated.

💬 “Before the treatment, even getting ready for bed was painful. I struggled to find a comfortable position, waking up constantly, exhausted. Now, I fall asleep easily, wake up refreshed with a new sense of freedom and no longer carry the weight of chronic pain.” – Aziza, trial participant

From our small cohort of 15 patients, almost everyone had similar stories. We were struck by how many patients had resigned themselves to live in constant nagging pain and the personal losses they had come to accept. Many spoke about missing out on simple joys: playing with grandchildren, gardening, or dancing.

As the effects of Sakura Bead took hold, patients told us how some of those lost moments had returned. Their gratitude toward their doctors, and the treatment, was so heartfelt and very motivational for all of us.

This is just the beginning. With our SURE Clinical Trial now launching across the U.S., we’re one step closer to making this minimally invasive treatment available to the millions still struggling with knee OA pain.